Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegylated Interferon Lambda for Treatment of COVID-19
NCT04534673Phase 2Completed
- Sponsor
- Soroka University Medical Center
- Start
- Apr 2020
- Primary completion
- Feb 2023
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon lambda-1a in coronavirus disease 2019 (COVID-19), sponsored by Soroka University Medical Center. Started Apr 2020; status: completed.
02
Drugs
peginterferon lambda-1a
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04534673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04534673.